BACKGROUND: Clinicians increasingly utilize polymyxins for treatment of serious infections caused by multidrug-resistant gram-negative bacteria. Emergence of plasmid-mediated, mobile colistin resistance genes creates potential for rapid spread of polymyxin resistance. We investigated the possible transmission of Klebsiella pneumoniae carrying mcr-1 via duodenoscope and report the first documented healthcare transmission of mcr-1-harboring bacteria in the United States. METHODS: A field investigation, including screening targeted high-risk groups, evaluation of the duodenoscope, and genome sequencing of isolated organisms, was conducted. The study site included a tertiary care academic health center in Boston, Massachusetts, and extended to community locations in New England. RESULTS: Two patients had highly related mcr-1-positive K. pneumoniae isolated from clinical cultures; a duodenoscope was the only identified epidemiological link. Screening tests for mcr-1 in 20 healthcare contacts and 2 household contacts were negative. Klebsiella pneumoniae and Escherichia coli were recovered from the duodenoscope; neither carried mcr-1. Evaluation of the duodenoscope identified intrusion of biomaterial under the sealed distal cap; devices were recalled to repair this defect. CONCLUSIONS: We identified transmission of mcr-1 in a United States acute care hospital that likely occurred via duodenoscope despite no identifiable breaches in reprocessing or infection control practices. Duodenoscope design flaws leading to transmission of multidrug-resistant organsisms persist despite recent initiatives to improve device safety. Reliable detection of colistin resistance is currently challenging for clinical laboratories, particularly given the absence of a US Food and Drug Administration-cleared test; improved clinical laboratory capacity for colistin susceptibility testing is needed to prevent the spread of mcr-carrying bacteria in healthcare settings.
BACKGROUND: Clinicians increasingly utilize polymyxins for treatment of serious infections caused by multidrug-resistant gram-negative bacteria. Emergence of plasmid-mediated, mobile colistin resistance genes creates potential for rapid spread of polymyxin resistance. We investigated the possible transmission of Klebsiella pneumoniae carrying mcr-1 via duodenoscope and report the first documented healthcare transmission of mcr-1-harboring bacteria in the United States. METHODS: A field investigation, including screening targeted high-risk groups, evaluation of the duodenoscope, and genome sequencing of isolated organisms, was conducted. The study site included a tertiary care academic health center in Boston, Massachusetts, and extended to community locations in New England. RESULTS: Two patients had highly related mcr-1-positive K. pneumoniae isolated from clinical cultures; a duodenoscope was the only identified epidemiological link. Screening tests for mcr-1 in 20 healthcare contacts and 2 household contacts were negative. Klebsiella pneumoniae and Escherichia coli were recovered from the duodenoscope; neither carried mcr-1. Evaluation of the duodenoscope identified intrusion of biomaterial under the sealed distal cap; devices were recalled to repair this defect. CONCLUSIONS: We identified transmission of mcr-1 in a United States acute care hospital that likely occurred via duodenoscope despite no identifiable breaches in reprocessing or infection control practices. Duodenoscope design flaws leading to transmission of multidrug-resistant organsisms persist despite recent initiatives to improve device safety. Reliable detection of colistin resistance is currently challenging for clinical laboratories, particularly given the absence of a US Food and Drug Administration-cleared test; improved clinical laboratory capacity for colistin susceptibility testing is needed to prevent the spread of mcr-carrying bacteria in healthcare settings.
Authors: Nenad Macesic; Sabrina Khan; Marla J Giddins; Daniel E Freedberg; Susan Whittier; Daniel A Green; E Yoko Furuya; Elizabeth C Verna; Medini K Annavajhala; Angela Gomez-Simmonds; Anne-Catrin Uhlemann Journal: Antimicrob Agents Chemother Date: 2019-05-24 Impact factor: 5.191
Authors: Sydney A Jones; Jefferson M Jones; Vivian Leung; Allyn K Nakashima; Kelly F Oakeson; Amanda R Smith; Robert Hunter; Janice J Kim; Melissa Cumming; Eileen McHale; Pampee P Young; Joy L Fridey; Walter E Kelley; Susan L Stramer; Stephen J Wagner; F Bernadette West; Ross Herron; Edward Snyder; Jeanne E Hendrickson; David R Peaper; Adi V Gundlapalli; Charles Langelier; Steve Miller; Ashok Nambiar; Morvarid Moayeri; Jack Kamm; Heather Moulton-Meissner; Pallavi Annambhotla; Paige Gable; Gillian A McAllister; Erin Breaker; Erisa Sula; Alison Laufer Halpin; Sridhar V Basavaraju Journal: MMWR Morb Mortal Wkly Rep Date: 2019-06-14 Impact factor: 17.586
Authors: Massimo Ciccozzi; Eleonora Cella; Alessia Lai; Lucia De Florio; Francesca Antonelli; Marta Fogolari; Francesco Maria Di Matteo; Margherita Pizzicannella; Benedetta Colombo; Giordano Dicuonzo; Silvia Angeletti Journal: Front Public Health Date: 2019-08-06
Authors: Cori L Ofstead; Brandy L Buro; Krystina M Hopkins; John E Eiland; Harry P Wetzler; David R Lichtenstein Journal: Endosc Int Open Date: 2020-11-17
Authors: Marco J Bruno; Margreet C Vos; Judith A Kwakman; Arjan W Rauwers; Corné H W Klaassen Journal: Antimicrob Resist Infect Control Date: 2021-08-28 Impact factor: 4.887
Authors: Maarten Heuvelmans; Herman F Wunderink; Henny C van der Mei; Jan F Monkelbaan Journal: Antimicrob Resist Infect Control Date: 2021-12-23 Impact factor: 4.887